netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Notes:

Cardiology-related Prescribing Guidance

Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.

Cardiology-related Shared Care Agreements

Please see our Shared Care Agreements page for all shared care agreements (SCAs) relating to this chapter.

 

 Details...
02.03.02  Expand sub section  Drugs for arrhythmias
02.03.02  Expand sub section  Supraventricular arrhythmias
Dronedarone 
(Tablet)
View adult BNF View SPC online
Formulary
Amber with Shared Care
  • Tablets 400mg
  • In line with NHSE guidance (June 2019) prescribers should not initiate dronedarone in primary care for any new patient. If there is a clinical need for dronedarone to be prescribed it must be in line with individual trust Shared Care Agreements - see links below.
 
Link  SFT/GWH Dronedarone Shared Care Document
Link  BCAP Dronedarone Shared Care Document
Link  Items which should not be routinely prescribed in primary care: Guidance for CCGs
Link  MHRA DSU Dec 2014: Dronedarone (Multaq¨‹): cardiovascular, hepatic and pulmonary adverse events ¨C new restrictions and monitoring requirements
Link  NICE TA197: Atrial fibrillation - dronedarone
   
Adenosine 
(Injection )
View adult BNF View SPC online
Formulary
Red
  • 6mg in 2ml
 
   
Regadenoson 
(Injection )
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Red
  • 400 micrograms in 5ml

  • RUH and GWH cardiology use for CMR perfusion imaging.
 
   
02.03.02  Expand sub section  Supraventricular and ventricular arrhythmias
02.03.02  Expand sub section  Ventricular arrhythmias
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG
Blueteq
High Cost Drug Approval System

Traffic Light Status Information

Status Description

Red

RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.  

Amber

Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.  

Amber with Shared Care

Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  

Green

These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.  

Self

Suitable for patient to be directed to buy themselves  

Grey

Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.   

Black

Not currently used. We intend to include this TLS in future to highlight where a decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.  

Red Specialist Centre

Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.  

netFormulary